Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences.
Invitae has launched a new genetic testing program, at no charge to participants, to test adults suspected of having — or at risk of developing — neurodegenerative disorders, including Parkinson’s ... Read more
Exercise can slow early cognitive decline in Parkinson’s disease patients who have a variant of the APOE gene, called APOE4, a recent study has found. “Additional research is needed to confirm ... Read more
People diagnosed with rheumatoid arthritis (RA) are at a significantly lower risk of developing Parkinson’s disease (PD) five or more years later, according to a large Swedish population study. This lesser risk — a ... Read more
An investigative disease-modifying treatment by Yumanity Therapeutics, called YTX-7739, was found to improve motor skills and lessen toxic protein clumping in a mouse model of Parkinson’s disease (PD), the company reported ... Read more
A project investigating a complex formed by two key proteins involved in Parkinson’s disease development has received nearly $150,000 in funding from the Michael J. Fox Foundation for Parkinson’s Research ... Read more
Tremor in Parkinson’s patients affects how well levodopa treatment, via dopamine production, affects learning skills in these people — supporting evidence of a link between tremor and cognition, a study found. ... Read more